Identifying Factors Underlying the Discontinuation of Triptans

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT00890357

Enrollment

292

Registered

2009-04-29

Start date

2009-08-31

Completion date

2012-06-30

Last updated

2013-03-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Medication Adherence, Migraine

Brief summary

The objective of this study is to identify reasons migraine patients stop using triptan medications for abortive headache treatment. It is hypothesized that inadequate education of the patient at the time of prescribing the triptan is positively associated with triptan discontinuation.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

Triptan User Inclusion Criteria: * Episodic Migraine or Chronic Migraine * Have used a triptan medication in the prior 3 months * Have used triptan medications for at least 1 year Triptan Discontinuation Inclusion Criteria: * Episodic Migraine or Chronic Migraine * Used any triptan medication in the last 2 years * Have not used a triptan medication in the last 6 months

Countries

United States

Outcome results